×
About 2,765 results

ALLMedicine™ Upper Respiratory Tract Infection Center

Research & Reviews  737 results

Infections or Vaccines Associated with Finkelstein-Seidlmayer Vasculitis: Systematic Re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096064
Clinical Reviews in Allergy & Immunology; Bronz G, Betti C et. al.

May 14th, 2022 - Finkelstein-Seidlmayer vasculitis, also referred to as acute hemorrhagic edema of young children, is a rare small-vessel leukocytoclastic vasculitis. This condition is skin-limited, mainly affects infants up to 2 years of age and spontaneously rem...

Chronic cough in asthma is associated with increased airway inflammation, more comorbid...
https://doi.org/10.2500/aap.2022.43.220022
Allergy and Asthma Proceedings; Deng SJ, Wang J et. al.

May 8th, 2022 - Background: Cough is often the most prominent and intractable symptom reported by patients with asthma, but few studies have explored the characteristics of patients with asthma and with chronic cough (CC) in a real-world setting. Methods: In a pr...

Large integrated safety analysis reinforces known safety profile of ixekizumab in PsA
https://www.mdedge.com/dermatology/article/254006/psoriatic-arthritis/large-integrated-safety-analysis-reinforces-known

Apr 25th, 2022 - Key clinical point: Ixekizumab demonstrated an overall consistent safety and tolerability profile with no unexpected/new adverse events (AE) in patients with psoriatic arthritis (PsA) and up to 3 years of exposure to ixekizumab. Major finding: Tre.

Correlation of initial upper respiratory tract viral burden with progression to lower t...
https://doi.org/10.1016/j.jcv.2022.105152
Journal of Clinical Virology : the Official Publication O... Ogimi C, Xie H et. al.

Apr 22nd, 2022 - Some respiratory viruses have been evaluated for the association between viral burden and respiratory disease progression in hematopoietic cell transplant (HCT) recipients, and no significant association has been reported. To assess whether initia...

ProAir Digihaler in COPD Disease Management: A Real World Study
https://clinicaltrials.gov/ct2/show/NCT04821869

Apr 20th, 2022 - The trial is an unblinded open label single center study designed to identify trends in Peak Inspiratory Flow (PIF) rates and Rescue Albuterol Inhaler usage (Inhalations) that associate with disease deterioration as defined by worsening of symptom...

see more →

Guidelines  1 results

Clinical practice guideline for the diagnosis and management of acute bacterial sinusit...
https://doi.org/10.1542/peds.2013-1071
Pediatrics Wald ER, Applegate KE et. al.

Jun 26th, 2013 - To update the American Academy of Pediatrics clinical practice guideline regarding the diagnosis and management of acute bacterial sinusitis in children and adolescents. Analysis of the medical literature published since the last version of the gu...

see more →

Drugs  48 results see all →

Clinicaltrials.gov  34 results

ProAir Digihaler in COPD Disease Management: A Real World Study
https://clinicaltrials.gov/ct2/show/NCT04821869

Apr 20th, 2022 - The trial is an unblinded open label single center study designed to identify trends in Peak Inspiratory Flow (PIF) rates and Rescue Albuterol Inhaler usage (Inhalations) that associate with disease deterioration as defined by worsening of symptom...

A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)
https://clinicaltrials.gov/ct2/show/NCT04583280

Apr 18th, 2022 - Respiratory syncytial virus (RSV), a negative-stranded ribonucleic acid (RNA) virus belonging to the Pneumoviridae family, is considered the most important cause of acute lower respiratory tract infection (LRTI) in infants and young children. In m...

Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)
https://clinicaltrials.gov/ct2/show/NCT00337675

Feb 7th, 2022 - This is a year-long study evaluating the efficacy of both daily and intermittent treatment of asthma in children who experience symptoms episodically (i.e., seasonally, usually in the context of upper respiratory tract infection).

Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care
https://clinicaltrials.gov/ct2/show/NCT02679781

Jan 14th, 2022 - Prospective, parallel design Study and control group: 100 healthy children (ASA 1), ages: 2-6 years, uncooperative (Frankl 1-2), that needs at least two similar dental treatments. Exclusion criteria: enlarged tonsils (Brodsky's grading scale11 +3 ...

Oral Corticosteroids for Post-infectious Cough in Adults
https://clinicaltrials.gov/ct2/show/NCT04232449

Dec 15th, 2021 - The purpose of this study is to assess whether a 5-day treatment with orally administered prednisone provides patient-relevant benefits by improving the cough-related QoL of patients with post-infectious cough triggered by an Upper Respiratory Tra...

see more →

News  285 results

Large integrated safety analysis reinforces known safety profile of ixekizumab in PsA
https://www.mdedge.com/dermatology/article/254006/psoriatic-arthritis/large-integrated-safety-analysis-reinforces-known

Apr 25th, 2022 - Key clinical point: Ixekizumab demonstrated an overall consistent safety and tolerability profile with no unexpected/new adverse events (AE) in patients with psoriatic arthritis (PsA) and up to 3 years of exposure to ixekizumab. Major finding: Tre.

Avapritinib Approved in Europe for Advanced Systemic Mastocytosis
https://www.onclive.com/view/avapritinib-approved-in-europe-for-advanced-systemic-mastocytosis

Mar 25th, 2022 - The European Commission has expanded the current indication for avapritinib (Ayvakyt) to include use as a single agent in adult patients with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematologic neoplasm, or mast ...

FDA Approves Generic Symbicort for Asthma, COPD
https://www.medscape.com/viewarticle/970360

Mar 16th, 2022 - The US Food and Drug Administration (FDA) approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 6 years of age and older and for the maintenance treatment ...

Second CAR T-Cell Therapy Approved for Myeloma
https://www.medpagetoday.com/hematologyoncology/myeloma/97437

Mar 1st, 2022 - The FDA approved ciltacabtagene autoleucel (cilta-cel; Carvykti), the second chimeric antigen receptor (CAR) T-cell therapy for adults with relapsed or refractory multiple myeloma, Janssen Pharmaceuticals announced. Ciltacabtagene autoleucel, a B-...

EU Panel Recommends Avapritinib for Advanced Systemic Mastocytosis
https://www.onclive.com/view/eu-panel-recommends-avapritinib-for-advanced-systemic-mastocytosis

Jan 31st, 2022 - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended to expand the current indication for avapritinib (Ayvakyt) to include use as a single agent in the treatment of adult patients with aggressive sy...

see more →

Patient Education  1 results see all →